| Stage | CRH | % of rev | MCK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $11.4B | 100.00% | $105B | 100.00% | MCK ×9.25 |
| Gross profit | $4.4B | 38.79% | $3.7B | 3.50% | CRH +35.3pp |
| Operating income | $1.9B | 16.64% | $1.3B | 1.25% | CRH +15.4pp |
| Pre-tax income | $1.7B | 15.08% | $1.3B | 1.24% | CRH +13.8pp |
| Net income | $1.2B | 10.39% | $1.0B | 0.98% | CRH +9.4pp |
| Stage | CRH | MCK | Gap · A − B |
|---|---|---|---|
| Revenue | $11.4B100.00% | $105B100.00% | MCK ×9.25 |
| Gross profit | 38.79%$4.4B | 3.50%$3.7B | CRH +35.3pp |
| Operating income | 16.64%$1.9B | 1.25%$1.3B | CRH +15.4pp |
| Pre-tax income | 15.08%$1.7B | 1.24%$1.3B | CRH +13.8pp |
| Net income |
| 10.39%$1.2B |
| 0.98%$1.0B |
| CRH +9.4pp |
None
No disclosed counterparties: CRH.